FOLTANX Trademark

Trademark Overview

On Friday, December 7, 2012, a trademark application was filed for FOLTANX with the United States Patent and Trademark Office. The USPTO has given the FOLTANX trademark a serial number of 85798031. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, January 25, 2024. This trademark is owned by Breckenridge Pharmaceutical, Inc.. The FOLTANX trademark is filed in the Pharmaceutical Products category with the following description:

Medical food supplement containing vitamins for the dietary management of endothelial dysfunction
foltanx

General Information

Serial Number85798031
Word MarkFOLTANX
Filing DateFriday, December 7, 2012
Status800 - REGISTERED AND RENEWED
Status DateThursday, January 25, 2024
Registration Number4372091
Registration DateTuesday, July 23, 2013
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 7, 2013

Trademark Statements

Goods and ServicesMedical food supplement containing vitamins for the dietary management of endothelial dysfunction

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 19, 2012
Primary Code005
First Use Anywhere DateWednesday, December 5, 2012
First Use In Commerce DateWednesday, December 5, 2012

Trademark Owner History

Party NameBreckenridge Pharmaceutical, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBerkeley Heights, NJ 07922
Party NameBreckenridge Pharmaceutical, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoca Raton, FL 33487
Party NameBreckenridge Pharmaceutical, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoca Raton, FL 33487

Trademark Events

Event DateEvent Description
Thursday, February 7, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 11, 2012NEW APPLICATION ENTERED
Wednesday, December 19, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 7, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 25, 2013ASSIGNED TO EXAMINER
Monday, March 25, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 17, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 7, 2013PUBLISHED FOR OPPOSITION
Tuesday, May 7, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 23, 2013REGISTERED-PRINCIPAL REGISTER
Monday, July 23, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, October 3, 2018TEAS SECTION 8 & 15 RECEIVED
Tuesday, October 16, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, October 16, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, October 16, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, July 23, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, July 24, 2023TEAS SECTION 8 & 9 RECEIVED
Monday, January 22, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, January 25, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, January 25, 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, January 25, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, June 20, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 20, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 20, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, June 20, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED

Related Keywords

foltanx management endothelial dysfunction dietary vitamins food supplement containing medical